Peptides

What this world covers

Peptides are short amino acid chains that act as signaling molecules, hormones or growth factors. This world covers the peptide classes relevant to biohacking: GLP-1 agonists (semaglutide, tirzepatide) for weight and metabolic regulation, GH secretagogues (CJC-1295, ipamorelin) for the GH/IGF-1 axis, healing peptides (BPC-157, TB-500), cosmetically active ones (GHK-Cu), immunomodulators (thymosin alpha-1) and sexual function (PT-141).

More important than the list is evidence stratification: GLP-1 agonists have Phase III data and are approved medications. GHK-Cu has solid dermatological data. The rest — BPC-157, TB-500, CJC-1295, ipamorelin, thymosin alpha-1 — rests largely on animal data, small uncontrolled studies and forum anecdotes. That's not a statement against their use; it's a statement against treating them as "proven."

Why the order matters

Peptides come after vitamins and methods in the world logic — not because they're particularly advanced, but because their risk-reward ratio is bad without an intact foundation. Anyone injecting peptides without sleep quality, strength training and proper micronutrients is compensating gaps with risk molecules that lifestyle would fill better.

Pragmatically: 1) foundation (World 01), 2) methods (World 02), 3) hormone profile (World 03), 4) targeted micronutrient and adaptogen correction — only then the peptide question. Anyone reversing this order chases effects that would be cheaper, safer and more sustainable from groundwork.

The most important levers

GLP-1 agonists (semaglutide, tirzepatide)

The only peptides in this world with large Phase III data and cardiovascular outcome evidence. Mechanism: central appetite suppression via GLP-1 and GIP receptors, delayed gastric emptying, improved insulin sensitivity.

Study data:

• SURMOUNT-1 (tirzepatide): −22.5 % body weight over 72 weeks
• STEP-1 (semaglutide): −14.9 % body weight over 68 weeks
• SELECT (semaglutide): −20 % cardiovascular endpoints

Trade-offs:

• Nausea, vomiting, constipation (30–60 % of patients)
• Muscle mass loss up to 25 % of total loss without strength training
• High rebound after discontinuation
• Only under medical prescription and supervision

BPC-157

The most popular healing peptide in biohacking forums. Derived from a body-own gastric protective peptide. Animal data reproducibly show accelerated healing of tendons, bones, cartilage, mucosa — in rats and mice.

Human evidence:

• No published RCTs
• Small case reports and uncontrolled athlete accounts
• Anecdotes often positive but methodologically not useful

Practical status: not an approved medication in the EU, sourcing legally problematic, self-use sits outside the evidence base. Anyone using it should know that.

GH secretagogues (CJC-1295, ipamorelin)

Synthetic peptides that stimulate GHRH or ghrelin receptors and raise endogenous GH pulses. Effects on IGF-1 measurable (+50–100 % in small studies). Effects on body composition: moderate fat loss, slight muscle gain over 8–12 weeks.

Important trade-off discussion:

Higher IGF-1 is not clearly "younger" or "better." Several large cohort studies (Laron syndrome, centenarian studies) show that lower IGF-1 correlates with longer lifespan. Anyone using GH peptides should take the longevity debate seriously — the short-term performance boost may be paid for with long-term cancer risk trade-off.

GHK-Cu

Copper peptide with the most robust dermatological evidence base of any peptide. Topically (serums, creams) at 0.05–0.2 % concentration: collagen synthesis, wrinkle reduction, wound healing documented in multiple small RCTs. Systemically (injection): few human data, anecdotal wound healing reports.

Practical status: evidence-based topical complement to retinoids. Not to be viewed as an anti-aging miracle or systemic healing booster.

How we rate evidence

In peptides the evidence discussion is decisive — much more than with vitamins or lifestyle methods. We weight:

1. Phase III RCTs with ≥ 1000 participants (gold standard for approved peptides)
2. Small RCTs / Phase II studies in humans
3. Case reports and uncontrolled studies in humans
4. Animal data (rat, mouse, monkey) — explicitly tagged as hypothesis-generating
5. In vitro and mechanistic — only worth mentioning, not action-guiding

For every peptide in this world there's an evidence label: "human RCT evidence," "animal data only," "anecdotal / uncontrolled." That's not a political statement, it's a scientific hygiene measure.

Most common effects and interactions

Peptides interact with body-own hormone production and must be dosed accordingly:

• GH secretagogues suppress endogenous GHRH sensitivity over time — pulse instead of running them continuously.
• GLP-1 agonists slow gastric emptying — other oral medications and supplements absorb more slowly.
• BPC-157 / TB-500 anecdotally synergize (gut healing + tendon); human data on this don't exist.
• GHK-Cu topically + retinoids are compatible, but apply retinoids 30 min after (pH compatibility).
• Semaglutide + insulin / sulfonylureas strongly raises hypoglycemia risk — physician dose adjustment necessary.

What does NOT belong in this world

• Classical hormone substitution (TRT, HRT, L-thyroxine) → World 03 (Hormones)
• Amino acid supplements like BCAAs, citrulline → World 07 (Performance)
• Neuropeptides for mood without official indication → World 09 (Mental)
• Topical cosmetic peptides more broadly (collagen triggers, snake venom mimetics) → outside the world logic

Insulin is a peptide and life-essential for diabetics but belongs primarily in endocrinological care — not a biohacking world.

How Biohacking AI operationalizes this

This world is more of an evidence filter than an optimization engine — and that's intentional:

1. The Peptide Tracker logs use, doses and subjective effects — but tags each peptide red/yellow/green for evidence tier, so you never get the impression everything is equally well-supported.
2. The Studies database shows human studies first for each peptide — and when none exist, that's stated loudly instead of being papered over with animal data.
3. The Forum has stricter moderation than other worlds: no purchase links, no sourcing info, clear disclaimers on regulatory status.
4. The Coach is more cautious here than elsewhere — recommending medical guidance with unclear evidence rather than self-optimization.

The goal is not "more peptides." The goal is: deploy the few peptides with real evidence correctly — and on the rest, name the uncertainty honestly instead of painting over it with hope.